Korro Bio (KRRO) Return on Sales (2019 - 2026)

Korro Bio's Return on Sales history runs 7 years deep, the most recent figure standing at 0.08% for Q1 2026.

• Quarterly Return on Sales rose 17.0% year-over-year to 0.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.08% (up 8.0% YoY) and the FY2025 annual result came in at 0.04%, up 4.0% from the prior year.
• Return on Sales was 0.08% for Q1 2026 at Korro Bio, down from 0.72% in the prior quarter.
• Across five years, Return on Sales topped out at 0.72% in Q4 2025 and bottomed at 0.18% in Q2 2025.
• A 4-year average of 0.08% and a median of 0.09% in 2025 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales fell 5 bps — and 2025, when it jumped 44 bps.
• Korro Bio's Return on Sales stood at 0.09% in 2022, then soared by 395 bps to 0.27% in 2024, then soared by 162 bps to 0.72% in 2025, then slumped by 89 bps to 0.08% in 2026.
• Business Quant data shows KRRO's Return on Sales at 0.08% in Q1 2026, 0.72% in Q4 2025, and 0.17% in Q3 2025.